Literature DB >> 7602327

Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat.

U K Zettl1, R Gold, K V Toyka, H P Hartung.   

Abstract

Apoptosis plays a critical role in natural recovery from experimental autoimmune disorders of the nervous system. Here we investigated in experimental autoimmune neuritis (EAN) whether apoptosis is augmented by high-dose corticosteroids, the mainstay of therapeutically active compounds in this group of disorders. Adoptive transfer EAN was induced by intravenous injection of P2-specific T cell blasts. At disease onset or at the maximum of disease two pulses of steroids were given within 12 hours, and animals were sacrificed 6 hours later. Steroid therapy significantly reduced T cell infiltration in sciatic nerve. Treatment on both day 4 and day 7 caused a significant increase of T cell apoptosis (42% vs 8.4% in placebo-treated animals on day 4, p < 0.05; 22.5% vs 7.0% on day 7, p < 0.05) in sciatic nerve as assessed by molecular labeling techniques. In addition, reduction of body weight and thymus weight and augmentation of thymocyte apoptosis were observed in steroid recipients. Steroid treatment markedly reduced cellular proliferation in lymphoid organs as measured by bromodeoxyuridine incorporation. Glucocorticosteroid treatment augments T cell apoptosis in inflammatory lesions of the peripheral nervous system, and this may add to their anti-inflammatory properties mediated by downregulation of cytokine expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7602327     DOI: 10.1097/00005072-199507000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  9 in total

1.  Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.

Authors:  M Stienekemeier; K Falk; O Rötzschke; A Weishaupt; C Schneider; K V Toyka; R Gold; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition.

Authors:  J Bauer; M Bradl; W F Hickley; S Forss-Petter; H Breitschopf; C Linington; H Wekerle; H Lassmann
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 3.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.

Authors:  A Weishaupt; R Gold; S Gaupp; G Giegerich; H P Hartung; K V Toyka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 5.  Apoptosis: clinical relevance and pharmacological manipulation.

Authors:  U Thatte; S Dahanukar
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

6.  Effect of methylprednisolone on mammalian neuronal networks in vitro.

Authors:  Matthias Wittstock; Paulus S Rommer; Florian Schiffmann; Konstantin Jügelt; Simone Stüwe; Reiner Benecke; Dietmar Schiffmann; Uwe K Zettl
Journal:  Cell Mol Neurobiol       Date:  2014-10-05       Impact factor: 5.046

7.  Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients.

Authors:  Paulus Stefan Rommer; Frank Kamin; Mazen Abu-Mugheisib; Wolfgang Koehler; Frank Hoffmann; Alexander Winkelmann; Reiner Benecke; Uwe Klaus Zettl
Journal:  CNS Neurosci Ther       Date:  2015-11-20       Impact factor: 5.243

Review 8.  T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms.

Authors:  R Gold; H P Hartung; H Lassmann
Journal:  Trends Neurosci       Date:  1997-09       Impact factor: 13.837

Review 9.  Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.

Authors:  Paolo Ripellino; Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Autoimmune Dis       Date:  2014-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.